These success, along with a past report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 help the idea of targeting ACKR3 as a novel approach to modulate the opioid process, which could open new therapeutic avenues for opioid-connected Conditions.These effects advise that conolidine is ready to restri